TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Cash and short-term investments (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $4.1B | −36.4% | −0.4% | 36.4% |
| Cash and short-term investments (Q2 2026) | $4.1B |
|---|---|
| YoY | −36.4% |
| 5-year CAGR | −0.4% |
| 10-year CAGR | 36.4% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2025 | $10.1B | +81.4% |
| 2024 | $5.6B | −31.1% |
| 2023 | $8.1B | −5.2% |
| 2022 | $8.5B | +90.4% |
| 2021 | $4.5B | −56.6% |
| 2020 | $10.3B | +330.4% |
| 2019 | $2.4B | +14.1% |
| 2018 | $2.1B | +57.5% |
| 2017 | $1.3B | +69.8% |
| 2016 | $786M | +73.9% |
| 2015 | $452M | −66.6% |
| 2014 | $1.4B | −76.8% |
| 2013 | $5.8B | +619.9% |
| 2012 | $810M | −20.6% |
| 2011 | $1.0B | +10.2% |
| 2010 | $926M | −41.1% |
| 2009 | $1.6B | +22.0% |
| 2008 | $1.3B | +106.0% |
| 2007 | $625M | — |